{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:44:34Z","timestamp":1785285874265,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.clinthera.2010.06.014","type":"journal-article","created":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T08:53:18Z","timestamp":1279270398000},"page":"1165-1177","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan\/naproxen sodium 85\/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: A randomized, open-label, three-period crossover study in healthy volunteers"],"prefix":"10.1016","volume":"32","clinical-trial-number":[{"clinical-trial-number":"nct00875784","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Alienor","family":"Berges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Walls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly E.","family":"Lener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2010.06.014_bib1","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1526-4610.2007.00673.x","article-title":"Major therapeutic advances in the past 25 years","volume":"47","author":"Solomon","year":"2007","journal-title":"Headache."},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2010.06.014_bib2","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1212\/WNL.64.10_suppl_2.S4","article-title":"Targeting therapy for migraine: What to treat?","volume":"64","author":"Ramadan","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.clinthera.2010.06.014_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1526-4610.2009.01340.x","article-title":"Allodynia-associated symptoms, pain intensity and time to treatment: Predicting treatment response in acute migraine intervention","volume":"49","author":"Cady","year":"2009","journal-title":"Headache."},{"key":"10.1016\/j.clinthera.2010.06.014_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/01.wnl.0000316800.22949.20","article-title":"Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine [published correction appears in Neurology. 2009;72:1369]","volume":"71","author":"Silberstein","year":"2008","journal-title":"Neurology."},{"key":"10.1016\/j.clinthera.2010.06.014_bib5","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/j.1742-1241.2008.01935.x","article-title":"Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsatisfied with sumatriptan","volume":"62","author":"Newman","year":"2008","journal-title":"Int J Clin Pract."},{"key":"10.1016\/j.clinthera.2010.06.014_bib6","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.297.13.1443","article-title":"Sumatriptannaproxen for acute treatment of migraine: A randomized trial","volume":"297","author":"Brandes","year":"2007","journal-title":"JAMA."},{"key":"10.1016\/j.clinthera.2010.06.014_bib7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1468-2982.2004.00802.x","article-title":"Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan","volume":"24","author":"Scholpp","year":"2004","journal-title":"Cephalalgia."},{"key":"10.1016\/j.clinthera.2010.06.014_bib8","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.4065\/78.10.1214","article-title":"Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 Randomized, double-blind, placebo-controlled studies","volume":"78","author":"Winner","year":"2003","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.clinthera.2010.06.014_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1185\/030079905X28926","article-title":"Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: Results of a large double-blind placebo-controlled trial","volume":"21","author":"Loder","year":"2005","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.clinthera.2010.06.014_bib10","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1468-2982.2008.01806.x","article-title":"Consistency of response to sumatriptan\/naproxen sodium in a placebo-controlled, crossover study","volume":"29","author":"Lipton","year":"2009","journal-title":"Cephalalgia."},{"key":"10.1016\/j.clinthera.2010.06.014_bib11","first-page":"1196","article-title":"Opportunity for early intervention in a clinical trial setting","volume":"27","author":"Dodick","year":"2007","journal-title":"Cephalalgia."},{"key":"10.1016\/j.clinthera.2010.06.014_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.clinthera.2006.03.013","article-title":"A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults","volume":"28","author":"Wendt","year":"2006","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2010.06.014_bib17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0149-2918(96)80219-0","article-title":"Efficacy and tolerability of subcutaneous sumatriptan administered using the IMITREX STATdose System","volume":"18","author":"Mushet","year":"1996","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2010.06.014_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2125.1997.00555.x","article-title":"The haemodynamic effects of subcutaneous sumatriptan, a 5HT1-receptor agonist","volume":"43","author":"Hood","year":"1997","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2010.06.014_bib19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1526-4610.2009.01606.x","article-title":"Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine","volume":"50","author":"Haberer","year":"2010","journal-title":"Headache."},{"key":"10.1016\/j.clinthera.2010.06.014_bib22","series-title":"Statistical Methods in Medical Research","author":"Armitage","year":"1987"},{"key":"10.1016\/j.clinthera.2010.06.014_bib23","series-title":"Clinical Pharmacokinetics: Concepts and Applications","author":"Rowland","year":"1995"},{"key":"10.1016\/j.clinthera.2010.06.014_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11916-002-0009-6","article-title":"Triptans: Do they differ?","volume":"6","author":"Salonen","year":"2002","journal-title":"Curr Pain Headache Rep."},{"key":"10.1016\/j.clinthera.2010.06.014_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1526-4610.2004.04030.x","article-title":"Onset of effect of 5-HT1 B\/1 D agonists: A model with pharmacokinetic validation","volume":"44","author":"Fox","year":"2004","journal-title":"Headache."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810002055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810002055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,9]],"date-time":"2018-12-09T14:23:24Z","timestamp":1544365404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291810002055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0149291810002055"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2010.06.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}